The 19th International Congress on Thrombosis, organized by The Mediterranean League Against Thromboembolic Diseases, will be held in Tel Aviv, Israel on May 14 - 18, 2006 The 19th International Congress on Thrombosis, organized by The Mediterranean League Against Thromboembolic Diseases, will be held in Tel Aviv, Israel on May 14 - 18, 2006

FINAL TIMETABLE

Monday,
May 15, 2006
Tuesday,
May 16, 2006
Wednesday,
May 17, 2006
Thursday,
May 18, 2006
Tuesday, May 16, 2006

3 Parallel Halls

08:30 – 09:15

PLENARY

Aspirin resistance
A. Michelson, USA

 

 

09:15 – 10:00

PLENARY

Disorders of platelet function / Abnormalities of the platelet P2 receptors
M. Cattaneo, Italy

10:00 – 10:30

Coffee break, Exhibition and Poster Viewing
Sponsored by Bayer HealthCare AG

10:30 – 12:00

THROMBOTIC THROMBOCYTOPENIC PURPURA

ADAMTS 13 and TTP: Mechanism of the disease
R. Schneppenheim, Germany

Thrombotic thromboytopenic purpura: Another example of immunomediated thrombosis
P. Mannucci, Italy

Testing the role of ADAMTS13 in platelet adhesion under flow
B. Shenkman, Israel

NOVEL ANTITHROMBOTICS ORAL PRESENTATIONS

CANCER AND THROMBOSIS

Pathogenesis of thrombosis in cancer
F. Rickles, USA

Cancer and venous thromboembolism: Clinical implications of a strong association
P. Prandoni, Italy

Inhibition of heparanese and cancer progression by modified species of heparin
I. Vlodavsky, Israel

 

12:00 – 13:30

Lunch break, exhibition and poster viewing

13:30 – 15:00

EPIDEMIOLOGY OF THROMBOSIS

Modern life risks of venous thrombosis
F. Rosendaal, The Netherlands

Acquired risk factors of venous Thromboembolism in medical patients
P. Prandoni, Italy

Deep vein thrombosis and pulmonary embolism. The same disease?
M. Monreal, Spain

HIT ORAL PRESENTATIONS

FIBRINOLYSIS BASIC AND CLINICAL

Multiple pathways of fibrin degradation and the consequences for assay of fibrin degradation products
C. Kluft, The Netherlands

Expression of the fibrinolytic components in endometriosis
A. Estelles, Spain

Biomarkers to guide safety and efficacy of stroke thrombolysis
J. Montaner, Spain

15:00 – 15:30

Coffee break, Exhibition and Poster Viewing

15:30 – 17:00

CONTROVERSIES IN PROPHYLAXIS OF VTE
Sponsored by Astrazeneca

New strategies for prevention of deep vein thrombosis in orthopedic surgery
B. Eriksson, Sweden

Prophylaxis in non-surgical patients – harm or good?
S. Schulman, Canada

Prophylaxis for medical patients and for orthopedic surgery - geographic differences
F. Anderson, USA

CANCER AND THROMBOSIS ORAL PRESENTATIONS

INFLAMMATION & THROMBOSIS

Red blood cells in hemodynamics and hemostasis
S. Yedgar, Israel

Pathogenesis of acture coronary syndrome
L.M. Biassuci, Italy

Microinflammation monitoring: More questions than answers
S. Berliner, Israel

   
 
webmaster Home | Committees | Main Topics | Final Timetable | Final Program | Confirmed Sponsors and Exhibitors | General Information | Sponsorship and Exhibition | Useful Links